IRIS Institutional Research Information System - OPENBS Open Archive UniBS

COLLO, LUIGIA RINALDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.223
EU - Europa 2.489
AS - Asia 1.774
SA - Sud America 250
AF - Africa 17
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 8.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.181
CN - Cina 721
PL - Polonia 664
UA - Ucraina 590
SG - Singapore 539
IT - Italia 297
DE - Germania 262
HK - Hong Kong 250
BR - Brasile 232
FI - Finlandia 164
GB - Regno Unito 99
FR - Francia 97
TR - Turchia 95
IE - Irlanda 92
RU - Federazione Russa 87
IN - India 57
CH - Svizzera 37
VN - Vietnam 35
CA - Canada 25
BE - Belgio 24
AT - Austria 17
ID - Indonesia 17
IR - Iran 15
CZ - Repubblica Ceca 14
NL - Olanda 13
AU - Australia 11
SE - Svezia 10
EU - Europa 9
AR - Argentina 8
ES - Italia 8
MX - Messico 7
MA - Marocco 6
BD - Bangladesh 5
IQ - Iraq 5
PA - Panama 5
EC - Ecuador 4
KR - Corea 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
JO - Giordania 3
KZ - Kazakistan 3
UZ - Uzbekistan 3
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
JP - Giappone 2
KE - Kenya 2
LU - Lussemburgo 2
PT - Portogallo 2
TM - Turkmenistan 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
Totale 8.773
Salva come PNG Salva come JPEG
Città #
Warsaw 664
Woodbridge 481
Fairfield 463
Jacksonville 436
Singapore 375
Houston 280
Ashburn 279
Hong Kong 246
Ann Arbor 240
Cambridge 231
Chandler 229
Seattle 201
Beijing 185
Princeton 177
Wilmington 174
Nanjing 139
Dearborn 98
Brescia 95
New York 94
Dublin 92
Istanbul 84
Helsinki 70
Des Moines 65
The Dalles 56
Nanchang 54
Milan 38
Moscow 38
Hebei 37
Jiaxing 36
Munich 36
Basel 35
Dong Ket 34
Shenyang 34
Changsha 29
Tianjin 26
Jinan 25
Shanghai 25
San Donà Di Piave 24
São Paulo 23
Brussels 21
San Diego 20
London 18
Turku 18
Jakarta 16
Leawood 15
Pune 15
Hangzhou 14
Hefei 14
Kunming 14
Lancaster 13
San Francisco 13
San Mateo 13
Brno 12
Los Angeles 12
Rio de Janeiro 12
Boardman 11
Teramo 11
Lanzhou 10
Ningbo 10
Norwalk 9
Rome 9
Toronto 9
Ardabil 8
Augusta 8
Taizhou 8
Verona 8
Vienna 8
Zhengzhou 8
Assemini 7
Changchun 7
Fuzhou 7
Haikou 6
Montreal 6
Orange 6
Santa Clara 6
Belo Horizonte 5
Boston 5
Canberra 5
Chicago 5
Desenzano del Garda 5
Melbourne 5
Monmouth Junction 5
Nuremberg 5
Phoenix 5
Romola 5
Sarezzo 5
Somma Lombardo 5
Stockholm 5
Taiyuan 5
Trieste 5
Brasília 4
Brooklyn 4
Charlotte 4
Düsseldorf 4
Frankfurt am Main 4
Guangzhou 4
Guarulhos 4
Madrid 4
Mumbai 4
New Bedfont 4
Totale 6.465
Salva come PNG Salva come JPEG
Nome #
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 281
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 271
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 223
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 223
Ketamine enhances structural plasticity in human dopaminergic neurons: Possible relevance for treatment-resistant depression 189
Structural plasticity induced by ketamine in human dopaminergic neurons as mechanism relevant for Treatment-Resistant Depression 147
Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels 145
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 141
Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine 138
(2 R,6 R)-Hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans 136
Pluripotent Stem Cell Based Cultures to Study Key Aspects of Human Cerebral Cortex Development 131
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 126
Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs. 121
Ketamine increases the expression of GluR1 and GluR2 α-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cells 121
P2X1 receptor activation in HL60 cells. 120
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling 118
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 117
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 116
An antagonist-insensitive P2X receptor expressed in epithelia and brain 116
ATP mediated cytotoxicity in microglial cells. 116
Ketamine effects on mammalian target of rapamycin signaling in the mouse limbic system depend on functional dopamine D3 receptors 116
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 114
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 112
A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: Focus on dopaminergic system 112
The NMDA/D1 receptor complex as a new target in drug development 110
Purinoceptors in the central nervous system 110
P2X receptors: an emerging channel family. 107
Blockade of human P2X7 receptor function with a monoclonal antibody. 106
Tissue distribution of the P2X7 receptor 104
Immature neuronal phenotype derived from mouse skin precursor cells differentiated in vitro. 98
Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. 96
D3 receptor involvement in neurotrophic effects of amphetamine and cocaine on mesencephalic dopaminergic neurons 93
Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. 92
Alphα6-containing nicotinic acetylcholine receptors mediate nicotine-induced structural plasticity in mouse and human iPSC-derived dopaminergic neurons 92
Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential 92
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 91
Dopamine D3 receptor and beta-2 containing nicotinic acetylcholine receptor are critical in mediating nicotine effects on dopaminergic neurons morphology 91
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 90
Critical role of dopamine D3 receptor in structural plasticity generated by exposure to drugs of addiction in mesencephalic dopaminergic neurons 90
Attenuated acute effects of ketamine on mTOR pathway in the limbic system of dopamine D3 receptor knock-out mice 89
Distictive functions of a6b4 and other integrins in epithelial cells. 88
Alpha-synuclein aggregation in dopaminergic cells is modulated by glucose metabolism 88
A new isoform of the laminin receptor α7β1 is developmentally regulated in skeletal muscle. 87
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 87
Neuroadaptation mechanisms to nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor and nicotinic acetylcholine receptors. 87
CRISPR targeting of human induced pluripotent stem cells (HIPSCS) for lineage tracing of HIPSCS-derived neural stem cells during cortical development in vitro 87
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 86
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 86
Ketamine produces structural plasticity of mouse mesencephalic dopaminergic neurons via activation of Akt-mTOR pathway: role of dopamine D3 receptor. 86
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 85
Selective dopaminergic alpha-synuclein pathological changes following glucose deprivation "in vitro": implications for Parkinson's disease 84
Nicotine produces structural plasticity of mesencephalic dopaminergic neurons via activation of Akt-mTor pathway 84
Ketamine produces structural plasticity in dopaminergic neurons via co-activation of MEK-ERK and Akt-mTOR pathways: translation from mouse primary culture to human iPSC-derived neurons 83
Neurotrophic effects of cocaine on mouse mesencephalic dopaminergic neurons are mediated by dopamine D3 receptors 82
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 82
Human iPS cell-derived dopaminergic neurons reveal role for D3 receptors and mTOR in induction of structural plasticity by antiparkinson DA agonists 82
Ketamine produces structural plasticity in dopaminergic neurons in vitro via co-activation of MEK-ERK and Akt-mTOR pathways: role of BDNF and dopamine D3 receptor 82
Cell-type specific integrin variants with alternative α chain cytoplasmic domain 80
Testing the effect of dopamine agonists and of drugs of addiction on structural plasticity of dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 79
Distinct alpha7A-beta1 and alpha7B-beta1 integrin expression patterns during mouse development: alpha7A is restricted to skeletal muscle but alpha7B is expressed in striated muscle, vasculature, and nervous system. 78
Morphogenetic changes produced by cocaine and nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor 78
Differential onset of expression of alpha7 and beta1D integrins during mouse heart and skeletal muscle development. 77
Testing drugs for structural plasticity in dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 75
Nicotine enhances the neuroplasticity of dopamine neurons: role of dopamine D3 receptors and acetylcholine nicotinic receptors. 74
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 74
Gradient of integrin α6A expession in the myocardium during early heart development. 73
Dopamine agonists produce neurotrophic effects on mesencephalic dopaminergic neurons via dopamine D3 receptor activation 72
Effetti neurotrofici dei farmaci agonisti preferenziali D3 sui neuroni mesencefalici: implicazioni terapeutiche per la malattia di Parkinson. 72
Oxide Nanowires for Neuron Adhesion and Growth 72
Evidence for soluble Interleukin-2 receptor (IL-2) as immunosuppressive factor. 71
Myogenic conversion of NIH3T3 cells by exogenous MyoD family members: dissociation of terminal differentiation from myotube formation. 70
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 70
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 69
Neuroprotective effects of D2/D3 agonists in an "in vitro" model of dopaminergic degeneration 66
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. 65
Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings 65
Loss of Synaptic D1 Dopamine/N-Methyl-D-aspartate Glutamate Receptor Complexes in L-DOPA-Induced Dyskinesia in the Rat. 64
The integrin alpha6beta4 in epithelial and carcinoma cells 64
Nicotine enhances structural plasticity in mesencephalic dopaminergic neurons: involvement of dopamine D3 receptors and nicotinic acetylcholine receptors. 64
Long-term expansion of dopaminergic progenitors from human induced pluripotent stem cells (iPSCs) and differentiation into dopaminergic neurons in vitro and in vivo 64
Downregulation of dopamine D1/NMDA receptor complexes in the post synaptic densities of dyskinetic rats 63
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 61
Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. 60
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons 60
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons. 60
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 60
Nicotine produces neurotrophic effects on mesencephalic dopaminergic neurons: role of dopamine D3 receptors and nicotinic acetylcholine receptors 58
Involvement of nicotinic acetylcholine receptors and dopamine D3 receptors in structural plasticity of dopaminergic neurons 58
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. 55
Meccanismo molecolari e cellulari nel Morbo di Parkinson 54
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 48
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 44
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 42
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist 39
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 33
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 28
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 25
Involvement of DA D3 Receptors in Structural Neuroplasticity of Selected Limbic Brain Circuits: Possible Role in Treatment-Resistant Depression 25
Synergic action of L-acetylcarnitine and L-methylfolate in Mouse Models of Stress-Related Disorders and Human iPSC-Derived Dopaminergic Neurons 24
Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine 21
Totale 9.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020126 0 0 0 0 0 0 0 0 0 0 0 126
2020/20211.348 28 143 30 159 93 136 61 151 180 121 189 57
2021/2022667 62 140 4 18 9 19 30 43 30 75 54 183
2022/2023627 93 3 10 54 57 187 4 64 106 0 15 34
2023/2024651 41 10 52 53 32 147 28 23 131 17 14 103
2024/20251.733 2 40 24 253 157 118 135 35 240 165 367 197
Totale 9.145